Search

Your search keyword '"S Kaye, Spratt"' showing total 27 results

Search Constraints

Start Over You searched for: Author "S Kaye, Spratt" Remove constraint Author: "S Kaye, Spratt"
27 results on '"S Kaye, Spratt"'

Search Results

1. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury

2. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury.

3. Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5

4. A Designed Zinc-finger Transcriptional Repressor of Phospholamban Improves Function of the Failing Heart

5. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats

6. Engineered Zinc Finger–Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb Ischemia

7. Induction of angiogenesis in a mouse model using engineered transcription factors

9. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

10. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury

11. Regulation of an Endogenous Locus Using a Panel of Designed Zinc Finger Proteins Targeted to Accessible Chromatin Regions

12. Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site

13. Selective uptake and sustained expression of AAV vectors following subcutaneous delivery

14. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

15. Retroviral Particles Produced from a Stable Human-Derived Packaging Cell Line Transduce Target Cells with Very High Efficiencies

16. Enhanced Host Defense After Gene Transfer in the Murine p47phox-Deficient Model of Chronic Granulomatous Disease

17. Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A

18. Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A

19. Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes

20. Ocular gene transfer with self-complementary AAV vectors

21. ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates

22. Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity

23. 200. Administration of an Engineered Zinc Finger Transcriptional Factor which Activates FEGF-A Induces Angiogenesis Reduces Cell Death and Promotes Neurobehavioural Recovery after Spinal Cord Injury

24. 43. Targeting the Biology of Heart Disease: Engineered Zinc Finger Protein Repressors of Phospholamban as a Potential Therapy for Congestive Heart Failure

25. 931. Enhanced Cardiac Muscle Contractility Achieved by Engineered Zinc Finger Transcriptional Repressors of Phospholamban

26. 107. Use of Adeno-Associated Viral Vectors for Effective Delivery of Engineered Zinc Finger Protein Transcription Factors

27. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.

Catalog

Books, media, physical & digital resources